Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-21

Clinical Trial Update: Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pharmacodynamics, pharmacokinetics, safety and tolerability of PTH analog tablets in postmenopausal women with osteoporosis completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PTH Analog Tablets (parathyroid hormone analog tablet)

Snippet

Sponsor: Unigene Laboratories Inc. | Conditions: Postmenopausal Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2013-02-21